XTX Topco’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-185,118
Closed -$1.51M 4456
2026
Q1
$1.51M Buy
185,118
+159,755
+630% +$1.37M 0.03% 1077
2025
Q4
$264K Sell
25,363
-3,434
-12% -$36K 0.01% 2184
2025
Q3
$255K Buy
+28,797
New +$205K 0.01% 1638
2025
Q2
Sell
-44,455
Closed -$293K 2803
2025
Q1
$293K Buy
44,455
+23,786
+115% +$185K 0.02% 1428
2024
Q4
$180K Buy
+20,669
New +$297K 0.01% 1592

Other funds holding KURA

XTX Topco's KURA Position: Q2 2026 in Review

XTX Topco sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 185,118 shares — an estimated $1.51M sold.

XTX Topco first reported a position in KURA in Q4 2024 and held it in 5 quarters. The position peaked at $1.51M in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • XTX Topco reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 185,118 Kura Oncology shares in Q2 2026, an estimated $1.51M.
  • XTX Topco first reported a position in Kura Oncology in Q4 2024 and held it in 5 quarters.
  • XTX Topco's Kura Oncology position peaked at $1.51M in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.